Serum methylmalonic acid correlates with neuropathic pain in idiopathic Parkinson’s disease

• Published in: Neurological sciences Vol. 38; no. 10; pp. 1799 - 1804
• Main Authors: Park, Jin-Sung, Park, Donghwi, Ko, Pan-Woo, Kang, Kyunghun, Lee, Ho-Won
• Format: Journal Article
• Language: English
• Published: Milan Springer Milan 01.10.2017; Springer Nature B.V
• Subjects: Homocysteine; Levodopa; Medicine; Medicine & Public Health; Neurology; Neuroradiology; Neurosciences; Neurosurgery; Original Article; Pain; Parkinson's disease; Peripheral neuropathy; Positron emission tomography; Psychiatry; Spinal cord; Statistical analysis; Vitamin B12; Vitamin deficiency; Levodopa; Methylmalonic acid; Peripheral neuropathy; Vitamin B12; Parkinson’s disease
• ISSN: 1590-1874; 1590-3478
• DOI: 10.1007/s10072-017-3056-9

Recent studies have shown a relatively higher prevalence of peripheral neuropathy in idiopathic Parkinson’s disease (IPD). The hypothesis is that prolonged levodopa exposure causes vitamin B12 deficiency, which leads to peripheral neuropathy. The aim of our study was to find the relationship between vitamin B12 and its precursor methylmalonic acid (MMA) in IPD patients with neuropathic pain. We performed a cross-sectional study by enrolling consecutive 43 patients who were clinically tested positive for F-18 FP-CIT PET and 15 patients were diagnosed with peripheral neuropathy according to the Toronto clinical scoring system (TCSS). The severity of neuropathic pain was evaluated using total neuropathy scale, revised (TNSr), and Korean Neuropathic Pain Questionnaire (KNPQ). The correlations between age, IPD duration, levodopa equivalent dose (LED), UPDRS III, vitamin B12, MMA, and homocysteine levels were assessed. The prevalence rate of peripheral neuropathy in IPD patients was 35%. Among the serums assessed, MMA levels showed a positive correlation to TNSr and KNPQ in the IPD patients with peripheral neuropathy (TNSr r  = 0.882, p  < 0.001, KNPQ r  = 0.710, p  = 0.004), while Vitamin B12 and homocysteine showed no statistically significant correlation. Our study showed a prevalence of peripheral neuropathy in 35% of Korean IPD patients. The serum MMA positively correlated with the severity of neuropathic pain and this can be used as a useful marker in assessment of peripheral neuropathy in Parkinson’s disease.